Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly CEO Breaks From PhRMA, Innovators With Support For CREATES Act

Jul 17 2018

• By Michael Cipriano

Capitol House

Related Content

CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor

Jun 14 2018

Shared REMS: US FDA Wants Brisk Brand-Generic Talks, Might Give Unilateral Waivers

Jun 01 2018

REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'

May 18 2018

Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price

Jul 17 2018

REMS Barriers: US FDA Takes 'Foundational Step' To Improve Generic Access

Nov 09 2017

Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes

Jul 19 2017

EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event

Sep 22 2016

Related Companies

Eli Lilly and Company

Viatris Inc.

Additional Topics

United States Generic Drugs Pricing Debate Legislation Policy BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window